SCHEMBL26145372

SCHEMBL26145372

Oc1c(Cl)cc(Br)c2cc[nH]c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 2/20 0.42
AR P10275 1/20 0.39
AHR P35869 2/20 0.33
EGFR P00533 1/20 0.33
RHEB Q15382 1/20 0.33
CCR8 P51685 1/20 0.32
TSHR P16473 2/20 0.32
HSD17B10 Q99714 2/20 0.32
TTR P02766 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
RECQL P46063 1/20 0.32
PRKCI P41743 2/20 0.32
AXL P30530 1/20 0.32
KMT2A Q03164 1/20 0.31
MAOB P27338 1/20 0.31
PARP1 P09874 1/20 0.31
AURKA O14965 1/20 0.31
TPX2 Q9ULW0 1/20 0.31
THRB P10828 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26129610 0.81 CSNK2A1 (0.44) CSNK2A1ARAHREGFRRHEB
SCHEMBL24787431 0.78 CSNK2A1 (0.42) CSNK2A1AHREGFRRHEBCCR8
SCHEMBL21243088 0.78 CSNK2A1 (0.42) CSNK2A1AHREGFRRHEBCCR8
SCHEMBL24787445 0.74 CSNK2A1 (0.39) CSNK2A1AHREGFRRHEBHSD17B10
SCHEMBL29860220 0.72 AHR (0.42) CSNK2A1ARAHREGFRRHEB
SCHEMBL264807 0.72 AHR (0.42) CSNK2A1ARAHREGFRRHEB
SCHEMBL31341960 0.70 CSNK2A1 (0.38) CSNK2A1AHREGFRRHEBCCR8
SCHEMBL24787449 0.70 TNF (0.47) CSNK2A1ARAHREGFRRHEB
SCHEMBL31527469 0.70 CSNK2A1 (0.38) CSNK2A1ARAHREGFRCCR8
SCHEMBL4418773 0.70 CCR8 (0.40) AHRCCR8HSD17B10ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151002-A1 6-5 FUSED RINGS AS C5a INHIBITORS CHEMOCENTRYX, INC. 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151002-A1 6-5 FUSED RINGS AS C5a INHIBITORS C5AR1, C5AR2, C3AR1 CSNK2A1 2635/4885AR 2141/4885AHR 2160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.